Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Friday, November 13, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
Authors
Posts by Ogkologos
Ogkologos
4398 POSTS
0 COMMENTS
ctDNA Monitoring Improves Early Relapse Detection After Treatment with Axicabtagene Ciloleucel...
Ogkologos
-
June 22, 2021
0
31-Year-Old Woman Diagnosed with Breast Cancer Just 11 Days Before Her...
Ogkologos
-
June 21, 2021
0
After Struggling With Chronic Illnesses Most of Her Life, This Author...
Ogkologos
-
June 21, 2021
0
Study Shows 4 Drugs Better Than 3 for Women with HER2-Positive...
Ogkologos
-
June 21, 2021
0
Nivolumab and Relatlimab Combination Shows Promise in Advanced Melanoma
Ogkologos
-
June 21, 2021
0
Signal of Increased Risk of Major Cardiovascular Events and Cancer with...
Ogkologos
-
June 21, 2021
0
10 Ways You Can Nurture A More Sustainable Garden
Ogkologos
-
June 18, 2021
0
Cancer Research UK spin-out gets US approval to trial unique T...
Ogkologos
-
June 18, 2021
0
Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant...
Ogkologos
-
June 18, 2021
0
Adding Checkpoint Inhibition to Anti-HER2 Breast Cancer Therapy Brings no Benefit...
Ogkologos
-
June 17, 2021
0
1
...
279
280
281
...
440
Page 280 of 440
MOST POPULAR
Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is...
October 19, 2020
Research with integrity – why colour blindness is a research integrity...
February 28, 2023
2022 ASCO Annual Meeting: Using Biomarker Testing to Avoid Radiation Therapy in...
June 7, 2022
Evidence for the Utility of ctDNA Monitoring for Recurrence After CRC...
October 3, 2024
Load more
HOT NEWS
A Combination of Osimertinib Plus Pemetrexed and a Platinum-based Agent Significantly...
Less Frequent Mammographic Surveillance Non-inferior Compared with Annual Mammograms After Diagnosis...
EMA Recommends Granting a Marketing Authorisation for Ensartinib
Neoadjuvant Nivolumab Plus Chemotherapy Results in Significantly Longer Event-Free Survival in...
Ελληνικά
English (UK)